PROMISE attending Antibody Industrial Symposium
Meet us at AIS meeting, Montpellier, 25th-26th June 2018
Labelled alpha-synuclein
Alpha-synuclein aggregates to form insoluble fibrils in pathological conditions characterized by Lewy bodies, such as Parkinson's disease, dementia with Lewy bodies and multiple system atrophy. These disorders are known as synucleinopathies. Alpha-synuclein is the primary structural component of Lewy body fibrils.